Major Stock Movers on Tuesday: RILY, ORGO, KYTX, RC, LWLG, and Others
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 16 2025
0mins
Source: SeekingAlpha
Market Overview: U.S. stock futures declined as investors remained cautious ahead of November's employment data, a crucial indicator for the labor market's health.
Biggest Gainers: B. Riley Financial shares surged by 28.5% after filing its overdue Q2 report, revealing a return to profitability, while Organogenesis Holdings rose 7.5% following FDA confirmation to initiate a rolling Biologics License Application for its knee osteoarthritis treatment.
Biggest Losers: Fractyl Health's shares fell 10.71% due to the cancellation of Tranche A warrants, and Kyverna Therapeutics dropped 6.7% after announcing a $100 million public offering despite positive clinical data.
Dividend Cuts and Offerings: Ready Capital's shares declined 9.44% after a drastic 92% dividend cut, and Lightwave Logic's stock slid 14.59% following the pricing of a $35 million public offering to boost cash reserves for commercialization and strategic purposes.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RC
Wall Street analysts forecast RC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RC is 2.43 USD with a low forecast of 2.05 USD and a high forecast of 2.75 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
0 Buy
2 Hold
1 Sell
Moderate Sell
Current: 2.210
Low
2.05
Averages
2.43
High
2.75
Current: 2.210
Low
2.05
Averages
2.43
High
2.75
About RC
Ready Capital Corporation is a multi-strategy real estate finance company that originates, acquires, finances and services lower-to-middle-market investor and owner-occupied commercial real estate loans. The Company specializes in loans backed by commercial real estate, including agency multifamily, investor, construction, and bridge as well as U.S. Small Business Administration loans under its Section 7(a) program. Its segments include LMM Commercial Real Estate and Small Business Lending. The LMM Commercial Real Estate segment originates lower-to-middle-market commercial real estate (LMM) loans across the full life cycle of an LMM property, including construction, bridge, stabilized and agency loan origination channels through its subsidiary, ReadyCap Commercial, LLC. The Small Business Lending segment acquires, originates and services owner-occupied loans guaranteed by the SBA under the SBA Section 7(a) Program through its subsidiary, ReadyCap Lending, LLC.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Travere Therapeutics Issues 2026 Outlook, Shares Plunge 28.2%
- Sales Forecast Downgrade: Travere Therapeutics expects U.S. net product sales of $410 million for 2025 and $127 million for Q4 2026, indicating pressure on future revenue growth that could undermine investor confidence.
- Clinical Trial Restart: The company plans to restart the Phase 3 HARMONY study in Q1 2026, aiming to advance product development, but this may not alleviate the short-term stock price decline.
- Severe Market Reaction: Shares of Travere Therapeutics plummeted 28.2% to $24.50 in pre-market trading, reflecting a pessimistic outlook from the market that may lead investors to reassess their strategies.
- Other Stock Volatility: Lulu’s Fashion Lounge Holdings surged 79% on acquisition news but fell 10.4% in pre-market trading, highlighting the high volatility in market sentiment that could impact the overall investment landscape.
Continue Reading
Heritage Global Inc (HGBL) Acquires Debt Exchange Assets, Shares Surge 19.1%
- Significant Stock Surge: Heritage Global Inc's shares rose 19.1% to $1.62 in pre-market trading, reflecting strong market confidence in the company's growth potential following the acquisition announcement.
- Acquisition Details: The company's subsidiary, Heritage DebtX, acquired substantially all assets of The Debt Exchange, which not only strengthens its asset base but also enhances its competitive position in the debt trading market.
- Strong Market Reaction: The acquisition news generated significant investor interest, with Heritage Global's stock performing notably well in pre-market trading, indicating market approval of its strategic direction.
- Future Growth Potential: This acquisition positions Heritage Global to capture a larger market share in debt management and trading, potentially leading to long-term revenue growth and business expansion opportunities.
Continue Reading